These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 37949621

  • 1. The Canadian Study of Arterial Inflammation in Patients with Diabetes and Recent Vascular Events, Evaluation of Colchicine Effectiveness (CADENCE): protocol for a randomised, double-blind, placebo-controlled trial.
    Boczar KE, Shin S, deKemp RA, Dowlatshahi D, Tavoosi A, Wiefels C, Liu P, Lochnan H, MacPherson PA, Chong AY, Torres C, Leung E, Tawakol A, Ahmadi A, Garrard L, Lefebvre C, Kelly C, MacPhee P, Tilokee E, Raggi P, Wells GA, Beanlands R.
    BMJ Open; 2023 Nov 10; 13(11):e074463. PubMed ID: 37949621
    [Abstract] [Full Text] [Related]

  • 2. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R, Mani V, Woodward M, Kallend D, Suchankova G, Fuster V, Rudd JHF, Tawakol A, Farkouh ME, Fayad ZA.
    JACC Cardiovasc Imaging; 2013 Oct 10; 6(10):1087-1094. PubMed ID: 24135322
    [Abstract] [Full Text] [Related]

  • 3. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging.
    Nitta Y, Tahara N, Tahara A, Honda A, Kodama N, Mizoguchi M, Kaida H, Ishibashi M, Hayabuchi N, Ikeda H, Yamagishi S, Imaizumi T.
    JACC Cardiovasc Imaging; 2013 Nov 10; 6(11):1172-82. PubMed ID: 24229770
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET/CT imaging study of carotid artery and ascending aorta.
    Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, Mawatari K, Yasukawa H, Kaida H, Ishibashi M, Hayabuchi N, Harada H, Ikeda H, Yamagishi S, Imaizumi T.
    JACC Cardiovasc Imaging; 2011 Oct 10; 4(10):1110-8. PubMed ID: 21999871
    [Abstract] [Full Text] [Related]

  • 5. Low-dose interleukin 2 for the reduction of vascular inflammation in acute coronary syndromes (IVORY): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase II clinical trial.
    Sriranjan R, Zhao TX, Tarkin J, Hubsch A, Helmy J, Vamvaka E, Jalaludeen N, Bond S, Hoole SP, Knott P, Buckenham S, Warnes V, Bird N, Cheow H, Templin H, Cacciottolo P, Rudd JHF, Mallat Z, Cheriyan J.
    BMJ Open; 2022 Oct 07; 12(10):e062602. PubMed ID: 36207050
    [Abstract] [Full Text] [Related]

  • 6. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study.
    Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, Farkouh ME, Fayad ZA.
    Circ Cardiovasc Imaging; 2009 Mar 07; 2(2):107-15. PubMed ID: 19808576
    [Abstract] [Full Text] [Related]

  • 7. The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial.
    Emami H, Vucic E, Subramanian S, Abdelbaky A, Fayad ZA, Du S, Roth E, Ballantyne CM, Mohler ER, Farkouh ME, Kim J, Farmer M, Li L, Ehlgen A, Langenickel TH, Velasquez L, Hayes W, Tawakol A.
    Atherosclerosis; 2015 Jun 07; 240(2):490-6. PubMed ID: 25913664
    [Abstract] [Full Text] [Related]

  • 8. Cohort profile: BIOVASC-late, a prospective multicentred study of imaging and blood biomarkers of carotid plaque inflammation and risk of late vascular recurrence after non-severe stroke in Ireland.
    McCabe JJ, Giannotti N, McNulty J, Collins S, Coveney S, Murphy S, Barry M, Harbison J, Cronin S, Williams D, Horgan G, Dolan E, Cassidy T, McDonnell C, Kavanagh E, Foley S, O'Connell M, Marnane M, Kelly P.
    BMJ Open; 2020 Jul 19; 10(7):e038607. PubMed ID: 32690537
    [Abstract] [Full Text] [Related]

  • 9. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CV events.
    Figueroa AL, Abdelbaky A, Truong QA, Corsini E, MacNabb MH, Lavender ZR, Lawler MA, Grinspoon SK, Brady TJ, Nasir K, Hoffmann U, Tawakol A.
    JACC Cardiovasc Imaging; 2013 Dec 19; 6(12):1250-9. PubMed ID: 24269261
    [Abstract] [Full Text] [Related]

  • 10. Anti-inflammatory effect of statin is continuously working throughout use: a prospective three time point 18F-FDG PET/CT imaging study.
    Kang MK, Kim CJ, Choo EH, Han EJ, Hwang BH, Kim JJ, Kim SH, O JH, Chang K.
    Int J Cardiovasc Imaging; 2019 Sep 19; 35(9):1745-1753. PubMed ID: 31312997
    [Abstract] [Full Text] [Related]

  • 11. Effect of Liraglutide on Arterial Inflammation Assessed as [18F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ripa RS, Zobel EH, von Scholten BJ, Jensen JK, Binderup T, Diaz LJ, Curovic VR, Hansen TW, Rossing P, Kjaer A.
    Circ Cardiovasc Imaging; 2021 Jul 19; 14(7):e012174. PubMed ID: 34187185
    [Abstract] [Full Text] [Related]

  • 12. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T.
    Int J Cardiovasc Imaging; 2016 Jan 19; 32(1):49-59. PubMed ID: 25898891
    [Abstract] [Full Text] [Related]

  • 13. Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis.
    Elkhawad M, Rudd JH, Sarov-Blat L, Cai G, Wells R, Davies LC, Collier DJ, Marber MS, Choudhury RP, Fayad ZA, Tawakol A, Gleeson FV, Lepore JJ, Davis B, Willette RN, Wilkinson IB, Sprecher DL, Cheriyan J.
    JACC Cardiovasc Imaging; 2012 Sep 19; 5(9):911-22. PubMed ID: 22974804
    [Abstract] [Full Text] [Related]

  • 14. A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography.
    deGoma EM, Salavati A, Shinohara RT, Saboury B, Pollan L, Schoen M, Torigian DA, Mohler ER, Dunbar RL, Litt HI, Woo J, Rader DJ, Alavi A, Mehta NN.
    Acad Radiol; 2015 May 19; 22(5):600-9. PubMed ID: 25708866
    [Abstract] [Full Text] [Related]

  • 15. Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT).
    Mehta NN, Torigian DA, Gelfand JM, Saboury B, Alavi A.
    J Vis Exp; 2012 May 02; (63):e3777. PubMed ID: 22588186
    [Abstract] [Full Text] [Related]

  • 16. Thresholds for Arterial Wall Inflammation Quantified by 18F-FDG PET Imaging: Implications for Vascular Interventional Studies.
    van der Valk FM, Verweij SL, Zwinderman KA, Strang AC, Kaiser Y, Marquering HA, Nederveen AJ, Stroes ES, Verberne HJ, Rudd JH.
    JACC Cardiovasc Imaging; 2016 Oct 02; 9(10):1198-1207. PubMed ID: 27639759
    [Abstract] [Full Text] [Related]

  • 17. Mineralocorticoid Receptor Antagonism by Eplerenone and Arterial Inflammation in HIV: The MIRABELLA HIV Study.
    Srinivasa S, Abohashem S, Walpert AR, Dunderdale CN, Iyengar S, Shen G, Jerosch-Herold M, deFilippi CR, Robbins GK, Lee H, Kwong RY, Adler GK, Tawakol A, Grinspoon SK.
    JAMA Cardiol; 2024 Feb 01; 9(2):189-194. PubMed ID: 38090987
    [Abstract] [Full Text] [Related]

  • 18. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
    Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, Subramanian SS, Abdelbaky A, Rudd JH, Farkouh ME, Nunes IO, Beals CR, Shankar SS.
    J Am Coll Cardiol; 2013 Sep 03; 62(10):909-17. PubMed ID: 23727083
    [Abstract] [Full Text] [Related]

  • 19. Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention.
    Ishii H, Nishio M, Takahashi H, Aoyama T, Tanaka M, Toriyama T, Tamaki T, Yoshikawa D, Hayashi M, Amano T, Matsubara T, Murohara T.
    Clin Ther; 2010 Dec 03; 32(14):2337-47. PubMed ID: 21353104
    [Abstract] [Full Text] [Related]

  • 20. Colchicine for Left Ventricular Infarct Size Reduction in Acute Myocardial Infarction: A Phase II, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Protocol - The COVERT-MI Study.
    Bresson D, Roubille F, Prieur C, Biere L, Ivanes F, Bouleti C, Dubreuil O, Rioufol G, Boutitie F, Sideris G, Elbaz M, Bochaton T, De Bourguignon C, El Jonhy N, Dufay N, Dhelens C, Croisille P, Prunier F, Angoulvant D, Ovize M, Maucort-Boulch D, Mewton N.
    Cardiology; 2021 Dec 03; 146(2):151-160. PubMed ID: 33582664
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.